doi: 10.1017/jme.2023.98.
Epub 2023 Dec 13.
Mifepristone Paternalism at the FDA
Affiliations
- PMID: 38088593
- DOI: 10.1017/jme.2023.98
Item in Clipboard
Mifepristone Paternalism at the FDA
J Law Med Ethics.
2023.
Abstract
This article explores the role of the Food and Drug Administration (FDA) in drug approval and restrictions to mifepristone access in the context of historical regulation and current litigation.
Keywords: Drug Regulation and Access; Food & Drug Administration; Medication Abortion; Risk Evaluation and Mitigation Strategies.
Similar articles
-
The Mifepristone Litigation: Untangling the Implications of the Fifth Circuit's Decision for Abortion Access and the U.S. Food and Drug Administration.Ann Intern Med. 2023 Dec;176(12):1666-1669. doi: 10.7326/M23-2431. Epub 2023 Nov 7. Ann Intern Med. 2023. PMID: 37931255 Review.
-
Brief of over 300 reproductive health researchers as Amici Curiae in FDA v. Alliance for Hippocratic Medicine.Perspect Sex Reprod Health. 2024 Dec;56(4):320-328. doi: 10.1111/psrh.12281. Epub 2024 Jul 29. Perspect Sex Reprod Health. 2024. PMID: 39074980
-
Update on medication abortion.J Midwifery Womens Health. 2007 Jan-Feb;52(1):23-30. doi: 10.1016/j.jmwh.2006.10.006. J Midwifery Womens Health. 2007. PMID: 17207747 Review.
-
History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion.J Health Polit Policy Law. 2023 Aug 1;48(4):485-510. doi: 10.1215/03616878-10449941. J Health Polit Policy Law. 2023. PMID: 36693178
-
Normalizing the exceptional: incorporating the "abortion pill" into mainstream medicine.Soc Sci Med. 2003 Jun;56(12):2353-66. doi: 10.1016/s0277-9536(02)00240-x. Soc Sci Med. 2003. PMID: 12742600
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
